Thyroid cancer: a review

L Boucai, M Zafereo, ME Cabanillas - Jama, 2024 - jamanetwork.com
Importance Approximately 43 720 new cases of thyroid carcinoma are expected to be
diagnosed in 2023 in the US. Five-year relative survival is approximately 98.5%. This review …

[HTML][HTML] Current advances in thyroid cancer management. Are we ready for the epidemic rise of diagnoses?

D Rusinek, E Chmielik, J Krajewska, M Jarzab… - International journal of …, 2017 - mdpi.com
A rising incidence of thyroid cancers (TCs) mainly small tumors, observed during recent
years, lead to many controversies regarding treatment strategies. TCs represent a distinct …

New therapeutic options for advanced forms of thyroid cancer

V Bernet, R Smallridge - Expert Opinion on Emerging Drugs, 2014 - Taylor & Francis
Introduction: While the vast majority of patients with thyroid cancer have an excellent
prognosis, those with more aggressive courses experience significant morbidity and …

[HTML][HTML] Multi-omics and management of follicular carcinoma of the thyroid

TE Luvhengo, I Bombil, A Mokhtari, MS Moeng… - Biomedicines, 2023 - mdpi.com
Follicular thyroid carcinoma (FTC) is the second most common cancer of the thyroid gland,
accounting for up to 20% of all primary malignant tumors in iodine-replete areas. The …

[图书][B] Thyroid cancer: a comprehensive guide to clinical management

L Wartofsky, D Van Nostrand - 2006 - Springer
are new to this edition. The authors provide not only the The second edition of Thyroid
Cancer: A Comp-most current review of their respective areas, but also their hensive Guide …

Evolution of the histologic classification of thyroid neoplasms and its impact on clinical management

B Xu, R Ghossein - European Journal of Surgical Oncology, 2018 - Elsevier
The vast majority of low grade follicular cell derived thyroid carcinomas follows an indolent
clinical course and is associated with very low mortality. Risk stratification using multiple …

[HTML][HTML] Molecular markers guiding thyroid cancer management

C Nylén, R Mechera, I Maréchal-Ross, V Tsang… - Cancers, 2020 - mdpi.com
The incidence of thyroid cancer is rapidly increasing, mostly due to the overdiagnosis and
overtreatment of differentiated thyroid cancer (TC). The increasing use of potent preclinical …

Biologic and clinical perspectives on thyroid cancer

JA Fagin, SA Wells Jr - New England Journal of Medicine, 2016 - Mass Medical Soc
Biologic and Clinical Perspectives on Thyroid Cancer | New England Journal of Medicine Skip to
main content The New England Journal of Medicine homepage Advanced Search SEARCH …

[HTML][HTML] Thyroid cancer: SEOM clinical guidelines

JM Trigo, J Capdevila, E Grande, J Grau… - Clinical and Translational …, 2014 - Springer
Thyroid cancer (TC) is the most common type of endocrine malignancy and accounts for
nearly 3% of all malignancies. The incidence of TC in Spain was 5/100,000 in women and …

Progress in treating advanced thyroid cancers in the era of targeted therapy

CC Lubitz, PM Sadow, GH Daniels, LJ Wirth - Thyroid, 2021 - liebertpub.com
Background: Thyroid cancer is a common malignancy whose detection has increased
significantly in past decades. Most of the increased incidence is due to detection of early …